Biomarkers for endometriosis study
Part of Women’s health & pregnancy clinical trials.
This study looks for biomarkers (biological signs) of endometriosis in women. It may help improve diagnosis and understanding of the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 45 years old.
- You have been diagnosed with active endometriosis via ultrasound, MRI, or laparoscopy.
- You are not currently on gonadotropin medications for fertility treatment.
- You have no current or past history of cancer (including uterine, ovarian, colon, pancreatic, or breast cancer) or any chronic illness.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for markers in body fluids (endometrial fluid, tissue, and follicular fluid) that might help understand moderate to severe endometriosis. Participating could give you more information about your condition and help researchers find better ways to diagnose and treat endometriosis.
This study collects blood and small tissue samples during planned gynecological surgery to better diagnose endometriosis and predict its course. It may help future patients by making diagnoses and outlook more accurate.
This study looks at how immune cells (NK cells) and uterine lining cells interact in endometriosis. It may help researchers understand why endometriosis causes pain and infertility.
This study tests whether a new blood test can accurately detect endometriosis (tissue similar to uterine lining growing outside the uterus). You may qualify if you menstruate regularly, are between 14–49 years old, and either have confirmed endometriosis, had a negative laparoscopy (a scope procedure), or have no endometriosis symptoms.
This study looks at immune cells and substances they release in women with endometriosis. The goal is to better understand the condition, which could lead to better treatments.
This study collects menstrual blood and cheek-swab DNA to better understand endometriosis. It may help researchers find markers that could eventually lead to earlier diagnosis and improved treatment planning.
Hear when a new Endometriosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.